Navigation Links
ShangPharma Appoints Pharmaceutical Executive Dr. Mitchell Reff Chief Biologics Officer
Date:1/13/2014

SHANGHAI, Jan. 13, 2014 /PRNewswire/ -- ShangPharma Corporation is pleased to announce that Dr. Mitchell Reff has joined the company as Chief Biologics Officer. Dr. Reff brings over 30 years of research and development experience in the biopharmaceutical industry. Dr. Reff's appointment further strengthens the world-class technical capabilities of ChemPartner's Biologics Division and offers Pharmaceutical and Biotechnology companies from around the world first-rate strategic and technical expertise to discover and manufacture novel first-in-class and best-in-class biologic clinical development candidates to advance into the Pharmaceutical and Biotechnology company pipelines.

Dr. Reff received his Ph.D. in Medical Microbiology from Stanford University School of Medicine, and his Bachelor's degree in Chemistry from Massachusetts Institute of Technology. This was followed by a  Postdoctoral Fellowship at Harvard Medical School, and  a position at the National Cancer Institute. Dr. Reff then spent 8 years at SmithKline Laboratories working on gene expression in mammalian cells and protein engineering. After that, he joined Idec Pharmaceuticals as head of molecular biology in 1990. Dr. Reff had a distinguished 21 year career at Idec, and later at Biogen Idec. He was Vice President Discovery Oncology at Biogen Idec running multiple bicoastal oncology groups developing small molecule and recombinant protein therapeutic molecules for oncology and delivered 6 novel oncology drugs into clinical trials in 5 years.

In early 1990s, Dr. Reff was Project Leader targeting B cell lymphoma, building and expressing the chimeric mouse-human anti-CD20 monoclonal antibody (Rituxan), the first monoclonal antibody approved to treat a tumor. Dr. Reff led the efforts from discovery until Rituxan entered its pivotal clinical trial.

Dr. Reff is well-recognized in the pharmaceutical and research community having been listed as an inventor on approximately 29 patents and patent applications, and as an author in nearly 100 scientific publications and presentations.

About ShangPharma:

ShangPharma Corp is a leading contract research organization (CRO) providing a broad range of high-quality, integrated services across both drug discovery and drug development to help pharmaceutical and biotechnology companies discover and develop novel drug candidates efficiently. The Company today has a team of nearly 2,000 skilled scientists in 1 million square feet of state-of-the-art research facilities and office space. For more information, please visit: http://www.ShangPharma.com. ChemPartner is a wholly owned subsidiary of ShangPharma Corp and also the main brand of the group.


'/>"/>
SOURCE ShangPharma
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ShangPharma Corporation Announces Completion of Merger
2. ShangPharma Corporation Announces Extraordinary General Meeting of Shareholders
3. ShangPharma Announces Third Quarter 2012 Results
4. ShangPharma to Report Third Quarter 2012 Financial Results on November 20, 2012
5. ShangPharma and Harbour Antibodies Announce Licensing Agreement
6. ShangPharma Announces Second Quarter 2012 Results
7. ShangPharma to Report Second Quarter 2012 Financial Results on August 20, 2012
8. ShangPharma Independent Committee Appoints Financial Advisor
9. ShangPharma Independent Committee Appoints Chairman and Legal Counsel
10. ShangPharma Announces Receipt of "Going Private" Proposal at $8.50 to $9.50 Per ADS
11. ShangPharma Announces First Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... Consolidated Stability Storage is Leading to CROs ... Outsourcing Market This research service on the global ... and technologies, and provides a snapshot of the key ... and forecasts are provided from 2016 to 2020. ... CAGR of 9.4% till 2020, driven by an explosion ...
(Date:1/23/2017)... -- MouthWatch LLC announced today that its flagship product, the ... intraoral camera on DentalCompare,s list of Top Dental Products ... product was the CollaPlug Absorbable Collagen Wound Dressing . ... popular because it is by far the most economical option ... it doesn,t sacrifice quality imaging." ...
(Date:1/23/2017)... , Jan. 23, 2017 7D Surgical ... clearance from the U.S. Food and Drug Administration ... Canada enabling the North American commercial launch of ... for spine surgery, the 7D Surgical System.  ... 3D optical technologies and machine vision algorithms to ...
Breaking Medicine Technology:
(Date:1/23/2017)... ... January 23, 2017 , ... The ... America for the scientific development, healthcare training and clinical application of medical infrared ... 2017 AAT Member Certification Qualification Courses for Technicians, respectively. , For the first ...
(Date:1/23/2017)... ... 23, 2017 , ... "ProRandom is a set of camera tools that allow video editors to ... Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , With ... with video footage. ProRandom works by using a virtual camera to create the illusion ...
(Date:1/23/2017)... ... January 23, 2017 , ... “Crossing the Bar”: a ... of a woman’s life. “Crossing the Bar” is the creation of published author, Charlotte ... , Charlotte, who credits the inspiration of the book to her sister, Denise, ...
(Date:1/22/2017)... SAINT- MALO, FRANCE (PRWEB) , ... January 22, 2017 , ... ... the Indian Ocean, isolated from the rest of the world with ZANZIBAR MILKY CREAM. ... Africa, Phytocéane used key ingredients like Virgin Coconut Oil and moisturizing vegetal coral to ...
(Date:1/21/2017)... , ... January 21, 2017 , ... Salveo for life, ... is bringing its product to the United States as part of its presence to ... 25 years, Alcovit aims to reduce the productions of nasty toxins as a result ...
Breaking Medicine News(10 mins):